EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Generic: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Zydus Pharmaceuticals USA Inc.Manufacturer
ORALRoute
EMTRICITABINEActive Substance
2020-02-28Original Approval
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is FDA application ANDA212689, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
773 reports
2
PATHOGEN RESISTANCE
751 reports
3
VIROLOGIC FAILURE
749 reports
4
VIRAL MUTATION IDENTIFIED
707 reports
5
DRUG RESISTANCE
502 reports
6
DRUG INEFFECTIVE
442 reports
7
MATERNAL EXPOSURE DURING PREGNANCY
413 reports
8
DRUG INTERACTION
353 reports
9
TREATMENT FAILURE
301 reports
10
ABORTION SPONTANEOUS
287 reports